Atlas Trials

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Clinical trial NCT04813627 · COMPLETED

Trial details

NCT number
NCT04813627
Sponsor
BioNTech SE
Status
COMPLETED
Study type
OBSERVATIONAL
Colorectal Cancer Stage IIColorectal Cancer Stage III
Start date
2021-07-02
Primary completion
2025-04-23
Enrollment
2079

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.